Mead Johnson Nutrition Co. (NYSE:MJN) rose 1.7% during trading on Wednesday . The stock traded as high as $85.45 and last traded at $85.19, with a volume of 1,367,322 shares changing hands. The stock had previously closed at $83.75.

MJN has been the subject of several recent research reports. Citigroup Inc. boosted their price target on shares of Mead Johnson Nutrition from $100.00 to $105.00 and gave the company a “buy” rating in a report on Monday, July 25th. Credit Suisse Group AG restated a “buy” rating and issued a $96.00 price target on shares of Mead Johnson Nutrition in a report on Thursday, June 30th. Zacks Investment Research upgraded shares of Mead Johnson Nutrition from a “hold” rating to a “buy” rating and set a $98.00 price target for the company in a report on Tuesday, May 3rd. Societe Generale lowered shares of Mead Johnson Nutrition from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $100.00 to $95.00 in a research note on Friday, July 29th. Finally, Deutsche Bank AG set a $88.00 price objective on shares of Mead Johnson Nutrition and gave the stock a “hold” rating in a research note on Sunday, July 24th. One equities research analyst has rated the stock with a sell rating, six have issued a hold rating and six have assigned a buy rating to the company. Mead Johnson Nutrition presently has an average rating of “Hold” and a consensus price target of $96.00.

The company’s 50 day moving average is $88.38 and its 200-day moving average is $84.20. The firm has a market cap of $15.72 billion and a price-to-earnings ratio of 32.03.

Mead Johnson Nutrition (NYSE:MJN) last posted its quarterly earnings data on Thursday, July 28th. The company reported $0.88 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.78 by $0.10. The business earned $941.50 million during the quarter, compared to analysts’ expectations of $967.25 million. During the same period in the previous year, the business posted $0.76 EPS. The company’s revenue for the quarter was down 8.8% compared to the same quarter last year. On average, analysts predict that Mead Johnson Nutrition Co. will post $3.52 earnings per share for the current fiscal year.

In related news, Director Kimberly A. Casiano sold 710 shares of Mead Johnson Nutrition stock in a transaction that occurred on Monday, August 15th. The shares were sold at an average price of $89.75, for a total value of $63,722.50. Following the completion of the transaction, the director now owns 7,110 shares in the company, valued at $638,122.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Graciela Monteagudo sold 45,873 shares of Mead Johnson Nutrition stock in a transaction that occurred on Friday, August 5th. The stock was sold at an average price of $87.64, for a total transaction of $4,020,309.72. Following the completion of the transaction, the senior vice president now owns 13,800 shares of the company’s stock, valued at approximately $1,209,432. The disclosure for this sale can be found here.

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.